These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 16492713)

  • 1. Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas.
    Zinzani PL; Quaglino P; Pimpinelli N; Berti E; Baliva G; Rupoli S; Martelli M; Alaibac M; Borroni G; Chimenti S; Alterini R; Alinari L; Fierro MT; Cappello N; Pileri A; Soligo D; Paulli M; Pileri S; Santucci M; Bernengo MG;
    J Clin Oncol; 2006 Mar; 24(9):1376-82. PubMed ID: 16492713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers.
    Senff NJ; Hoefnagel JJ; Jansen PM; Vermeer MH; van Baarlen J; Blokx WA; Canninga-van Dijk MR; Geerts ML; Hebeda KM; Kluin PM; Lam KH; Meijer CJ; Willemze R
    J Clin Oncol; 2007 Apr; 25(12):1581-7. PubMed ID: 17353548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of radiotherapy in 153 primary cutaneous B-Cell lymphomas classified according to the WHO-EORTC classification.
    Senff NJ; Hoefnagel JJ; Neelis KJ; Vermeer MH; Noordijk EM; Willemze R;
    Arch Dermatol; 2007 Dec; 143(12):1520-6. PubMed ID: 18087001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary cutaneous B-cell lymphoma treated with radiotherapy: a comparison of the European Organization for Research and Treatment of Cancer and the WHO classification systems.
    Smith BD; Glusac EJ; McNiff JM; Smith GL; Heald PW; Cooper DL; Wilson LD
    J Clin Oncol; 2004 Feb; 22(4):634-9. PubMed ID: 14966086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
    Grange F; Beylot-Barry M; Courville P; Maubec E; Bagot M; Vergier B; Souteyrand P; Machet L; Dalac S; Esteve E; Templier I; Delaporte E; Avril MF; Robert C; Dalle S; Laroche L; Delaunay M; Joly P; Wechsler J; Petrella T
    Arch Dermatol; 2007 Sep; 143(9):1144-50. PubMed ID: 17875875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The applicability and prognostic value of the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: results on a large cohort of primary cutaneous B-cell lymphomas and comparison with the system used by the Dutch Cutaneous Lymphoma Group.
    Senff NJ; Willemze R
    Br J Dermatol; 2007 Dec; 157(6):1205-11. PubMed ID: 17941944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic eight-cycle anti-CD20 monoclonal antibody (rituximab) therapy in primary cutaneous B-cell lymphomas--an applicational observation.
    Gellrich S; Muche JM; Wilks A; Jasch KC; Voit C; Fischer T; Audring H; Sterry W
    Br J Dermatol; 2005 Jul; 153(1):167-73. PubMed ID: 16029344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognosis of primary cutaneous lymphomas].
    Grange F; Bagot M
    Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):30-40. PubMed ID: 11937927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary cutaneous B-cell lymphomas. Current concepts. I.
    Santucci M; Pimpinelli N
    Haematologica; 2004 Nov; 89(11):1360-71. PubMed ID: 15531459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cutaneous B-cell lymphoma prognostic index: a novel prognostic index derived from a population-based registry.
    Smith BD; Smith GL; Cooper DL; Wilson LD
    J Clin Oncol; 2005 May; 23(15):3390-5. PubMed ID: 15908651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome and prognostic factors in ocular adnexal lymphoma.
    Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
    Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary cutaneous large B-cell lymphomas of the legs. A distinct type of cutaneous B-cell lymphoma with an intermediate prognosis. Dutch Cutaneous Lymphoma Working Group.
    Vermeer MH; Geelen FA; van Haselen CW; van Voorst Vader PC; Geerts ML; van Vloten WA; Willemze R
    Arch Dermatol; 1996 Nov; 132(11):1304-8. PubMed ID: 8915307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous B-cell lymphoma: pathological spectrum and clinical outcome in 51 consecutive patients.
    Sah A; Barrans SL; Parapia LA; Jack AS; Owen RG
    Am J Hematol; 2004 Apr; 75(4):195-9. PubMed ID: 15054808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival data for 299 patients with primary cutaneous lymphomas: a monocentre study.
    Hallermann C; Niermann C; Fischer RJ; Schulze HJ
    Acta Derm Venereol; 2011 Sep; 91(5):521-5. PubMed ID: 21547335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of bone marrow examination in 275 patients with histological features that suggest an indolent type of cutaneous B-cell lymphoma.
    Senff NJ; Kluin-Nelemans HC; Willemze R
    Br J Haematol; 2008 Jul; 142(1):52-6. PubMed ID: 18422781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary cutaneous B-cell lymphoma: classification and treatment.
    Willemze R
    Curr Opin Oncol; 2006 Sep; 18(5):425-31. PubMed ID: 16894288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease-free survival in a series of 137 patients.
    Servitje O; Muniesa C; Benavente Y; Monsálvez V; Garcia-Muret MP; Gallardo F; Domingo-Domenech E; Lucas A; Climent F; Rodriguez-Peralto JL; Ortiz-Romero PL; Sandoval J; Pujol RM; Estrach MT
    J Am Acad Dermatol; 2013 Sep; 69(3):357-65. PubMed ID: 23796549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary diffuse large B-cell lymphoma of the tonsil: is a higher radiotherapy dose required?
    Laskar S; Bahl G; Muckaden MA; Nair R; Gupta S; Bakshi A; Gujral S; Shet T; Shrivastava SK; Dinshaw KA
    Cancer; 2007 Aug; 110(4):816-23. PubMed ID: 17582622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Homogeneous clinical behavior of a group of cutaneous B-cell lymphomas].
    de Misa RF; Sastre JL; Azaña JM; Escribano L; Suárez J; Bellas C
    Sangre (Barc); 1995 Dec; 40(6):465-70. PubMed ID: 8850229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment and outcomes in patients with primary cutaneous B-cell lymphoma: the BC Cancer Agency experience.
    Hamilton SN; Wai ES; Tan K; Alexander C; Gascoyne RD; Connors JM
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):719-25. PubMed ID: 24001373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.